{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:21:42Z","timestamp":1790788902524,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.pcad.2005.06.005","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T09:31:51Z","timestamp":1132133511000},"page":"79-87","source":"Crossref","is-referenced-by-count":98,"title":["Asymptomatic Atrial Fibrillation"],"prefix":"10.1016","volume":"48","author":[{"given":"Robert W.","family":"Rho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2005.06.005_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.155.5.469","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pcad.2005.06.005_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"1 Pt 2","key":"10.1016\/j.pcad.2005.06.005_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1540-8159.1998.tb01098.x","article-title":"Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance","volume":"21","author":"Defaye","year":"1998","journal-title":"Pacing. Clin. Electrophysiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.CIR.72.5.1037","article-title":"Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: Role of contractility","volume":"72","author":"Ausubel","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2005.06.005_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9149(97)89297-1","article-title":"Effect of an irregular ventricular rhythm on cardiac output","volume":"78","author":"Daoud","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-9149(86)90836-2","article-title":"Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction","volume":"57","author":"Packer","year":"1986","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib7","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","article-title":"Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. The College of French Cardiologists","volume":"99","author":"Levy","year":"1999","journal-title":"Circulation"},{"issue":"Suppl C","key":"10.1016\/j.pcad.2005.06.005_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/eurheartj\/17.suppl_C.48","article-title":"Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation","volume":"17","author":"Kerr","year":"1996","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcad.2005.06.005_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2005.06.005_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.0000051455.44919.73","article-title":"Asymptomatic or \u201csilent\u201d atrial fibrillation: Frequency in untreated patients and patients receiving azimilide","volume":"107","author":"Page","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2005.06.005_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0002-8703(80)90733-4","article-title":"The rhythm of the heart in active elderly subjects","volume":"99","author":"Camm","year":"1980","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pcad.2005.06.005_bib12","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2005.06.005_bib13","first-page":"1025","article-title":"Mid-term clinical and prognostic evaluation of idiopathic atrial fibrillation","volume":"86","author":"Ciaroni","year":"1993","journal-title":"Arch. Mal. Coeur. Vaiss."},{"key":"10.1016\/j.pcad.2005.06.005_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9149(94)90363-8","article-title":"Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)","volume":"74","author":"Furberg","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.271.11.840","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2005.06.005_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.0000109490.72104.EE","article-title":"Canadian trial of physiological pacing: Effects of physiological pacing during long-term follow-up","volume":"109","author":"Kerr","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2005.06.005_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jacc.2003.08.027","article-title":"Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care","volume":"43","author":"Israel","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0167-5273(96)02631-9","article-title":"The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propanolol or propafenone","volume":"54","author":"Wolk","year":"1996","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib19","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.99.21.2765","article-title":"Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. Double-blind placebo controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation","volume":"99","author":"Murgatroyd","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2005.06.005_bib20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2005.06.005_bib21","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","article-title":"ACC\/AHA\/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary\u2014A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2005.06.005_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcad.2005.06.005_bib23","first-page":"195","article-title":"Canadian Trial of Atrial Fibrillation. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience","volume":"20","author":"Thibault","year":"2004","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. For the rate control versus electrical cardioversion for persistent atrial fibrillation study group","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcad.2005.06.005_bib25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcad.2005.06.005_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9149(96)00333-5","article-title":"Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation","volume":"78","author":"Falcone","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0002-8703(95)90253-8","article-title":"Left atrial appendage \u201cstunning\u201d after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography","volume":"130","author":"Grimm","year":"1995","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pcad.2005.06.005_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0002-9149(98)00089-7","article-title":"Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation","volume":"81","author":"Bellotti","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib29","doi-asserted-by":"crossref","first-page":"36D","DOI":"10.1016\/S0002-9149(00)00905-X","article-title":"Cost-effective management of acute atrial fibrillation: Role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy","volume":"85","author":"Naccarelli","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0735-1097(92)90530-Z","article-title":"Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter","volume":"19","author":"Arnold","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-126-8-199704150-00005","article-title":"Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours","volume":"126","author":"Weigner","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pcad.2005.06.005_bib32","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Assessment of cardioversion using transesophageal echocardiography investigators. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcad.2005.06.005_bib33","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0002-9149(92)90705-4","article-title":"Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy","volume":"69","author":"Grogan","year":"1992","journal-title":"Am. J. Cardiol."},{"issue":"4 Pt 1","key":"10.1016\/j.pcad.2005.06.005_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-8703(98)70012-2","article-title":"Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure","volume":"136","author":"Twidale","year":"1998","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pcad.2005.06.005_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4065\/75.8.790","article-title":"Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation","volume":"75","author":"Redfield","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.pcad.2005.06.005_bib36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1023\/B:CEPR.0000023165.20987.b1","article-title":"The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: Rationale, design, results, clinical implications and lessons for future trials","volume":"7","author":"Wilkoff","year":"2003","journal-title":"Card. Electrophysiol. Rev."},{"key":"10.1016\/j.pcad.2005.06.005_bib37","doi-asserted-by":"crossref","first-page":"29N","DOI":"10.1016\/S0002-9149(98)00737-1","article-title":"Rate issues in atrial fibrillation: Consequences of tachycardia and therapy for rate control","volume":"82","author":"Schumacher","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pcad.2005.06.005_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1540-8159.1996.tb04796.x","article-title":"Tachycardiomyopathy: Mechanisms and clinical implications","volume":"19","author":"Fenelon","year":"1996","journal-title":"Pacing Clin. Electrophysiol."}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062005000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062005000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T23:12:03Z","timestamp":1554505923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062005000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0033062005000332"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2005.06.005","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}